In the event of a failure to correct deficiencies Avient reserves a right to terminate this Agreement. 12.2 Supplier shall comply with all applicable (inter)national laws, rules and regulations, standards and orders in connection with the performance of the Agreement, including all applicable laws, rules and regulations on international trade, such as but not limited to embargos/sanctions, all import and export controls and screening against sanctioned party lists.

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 18 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% 450.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $39.28 April 4th, 2014 • 18 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 6 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 7 PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia 6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% Mix Shift Highlights Specialty Transformation Page 8 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 64% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 Q1 2014 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $60M Target 2015 Target Proof of Performance & 2015 Goals Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid single digit revenue CAGR Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 11 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 42.0% 2006 Q1 2014 Healthcare Consumer Packaging and Additive Technology Transportation Page 12 Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Investing in operational and initiatives that drive profitability growth Manufacturing realignment  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? ���PolyOne Investor Presentation�5th Annual Wells Fargo�Industrial and Construction Conference �May 8, 2014 �� Forward – Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Proof of Performance & 2015 Goals Bridge to $2.50 Adjusted EPS by 2015 Innovation Drives Earnings Growth Unique and Innovative Solutions Debt Maturities & Pension Funding – 3/31/14 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return Why Invest In PolyOne?

S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.5 million shares in Q3 2014 Repurchased 9.7 million shares since early 2013  10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne? ��PolyOne Investor Presentation�Goldman Sachs 2014 US Emerging / SMID Cap Growth Conference�New York, NY�November 20, 2014�� Forward-Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results Proof of Performance & 2015 Goals 32% Adjusted EPS CAGR from 2011 Innovation Drives Earnings Growth A Rich Pipeline of Opportunity Megatrends Aligned with Key End Markets Debt Maturities & Pension Funding – 9/30/14 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return PolyOne Core Values Why Invest In PolyOne?

< 10%) or no change Disposals ­ On­site Disposal (excluding Tailings and Waste Rock) CAS RN Substance Name Category Basis of Estimate Detail Code Quantity NA ­ 14 Zinc (and its compounds) Landfill O ­ Engineering Estimates 0.0002 tonnes Disposals ­ On­site Disposal (excluding Tailings and Waste Rock) ­ Total CAS RN Substance Name Total ­ On­site Disposals NA ­ 14 Zinc (and its compounds) 0.0002 tonnes Disposals ­ Total Quantity Disposed (All Media) CAS RN Substance Name Total Quantity Disposed (All Media) NA ­ 14 Zinc (and its compounds) 0.0002 tonnes Disposals ­ Reasons and Comments CAS RN Substance Name Reasons Why Substance Was Disposed Reasons for Changes in Quantities from Previous Year Comments 103­23­1 Bis(2­ethylhexyl) adipate No significant change (i.e. < 10%) or no change 117­81­7 Bis(2­ethylhexyl) phthalate No significant change (i.e. < 10%) or no change 85­68­7 Butyl benzyl phthalate No significant change (i.e. < 10%) or no change NA ­ 01 Antimony (and its compounds) No significant change (i.e. < 10%) or no change NA ­ 02 Arsenic (and its compounds) No significant change (i.e. < 10%) or no change NA ­ 14 Zinc (and its compounds) Production residues No significant change (i.e. < 10%) or no change About us News Contact us Stay connected HEALTH healthycanadians.gc.ca TRAVEL travel.gc.ca SERVICE CANADA servicecanada.gc.ca JOBS jobbank.gc.ca ECONOMY actionplan.gc.ca Canada.gc.ca Terms and Conditions Transparency Version: 3.13.0 Recycling ­ Reasons and Comments CAS RN Substance Name Reasons Why Substance Was Recycled Reasons for Changes in Quantities Recycled from Previous Year Comments 103­23­1 Bis(2­ethylhexyl) adipate No significant change (i.e. < 10%) or no change 117­81­7 Bis(2­ethylhexyl) phthalate No significant change (i.e. < 10%) or no change 85­68­7 Butyl benzyl phthalate No significant change (i.e. < 10%) or no change NA ­ 01 Antimony (and its compounds) No significant change (i.e. < 10%) or no change NA ­ 02 Arsenic (and its compounds) No significant change (i.e. < 10%) or no change NA ­ 14 Zinc (and its compounds) No significant change (i.e. < 10%) or no change Pollution Prevention Does the facility have a documented pollution prevention plan?

It is better to fill out the part at slower speeds in-order to let any compressed air escape, and to get the best surface finish on the part.3 • Using all of the previous settings, record the Transfer Pressure, Fill Time, and Injection speed • Reduce the injection velocity by 10% and record the same values • Keep reducing the injection velocity until a fill time of 10-15 seconds is reached Transfer Pressure (psi) Fill Time (sec) Injection Velocity (in/sec) Relative Shear Rate Relative Viscosity 1238 0.20 8.00 5.00 247.60 1125 0.22 7.00 4.55 247.50 1058 0.25 6.00 4.00 264.50 960 0.35 5.00 2.86 336.12 870 0.45 4.00 2.22 391.65 780 0.58 3.00 1.72 452.59 690 0.85 2.00 1.18 586.78 600 1.35 1.00 0.74 810.45 510 2.50 0.75 0.40 1275.83 420 5.23 0.50 0.19 2198.34 330 9.56 0.25 0.10 3157.99 240 15.26 0.10 0.07 3667.49 FIGURE 47 - Injection Speed 22 Gravi-Tech • Calculate the Relative Viscosity for each of the Injection Speeds using the equation above (Transfer Pressure * Fill Time) • Calculate the Relative Shear Rate for each of the injection speeds using the equation (1/Fill Time) • Plot the points on a graph and find the optimum velocity • The optimum velocity will be where the curve starts to level out In figure 48 above, the optimum velocity is where the plotted line crosses the black trend line; therefore the optimum velocity would be about 1.00 in/sec. This is why a mechanical unit should never be left clamped together; as it results in more wear on the machine and reduced stiffness in the clamping unit. Acknowledgments Avient would like to acknowledge the gracious input provided by the faculty of the Behrend Plastics Engineering Technology program at Penn State University.

FIBERS PROCESSES PRODUCTS MOVING HIGH PERFORMANCE FIBERS FORWARD VECTRAN® LIQUID CRYSTAL POLYMER WHY VECTRAN® LIQUID CRYSTAL POLYMER?

FIBERS PROCESSES PRODUCTS MOVING HIGH PERFORMANCE FIBERS FORWARD UHMWPE WHY UHMWPE?

Key Features • High tenacity & modulus • Excellent abrasion & fatigue resistance • Excellent chemical & steam resistance • Very low creep • High thermal stability • Lower moisture regain than other para-aramids Disadvantages • Lower modulus compared to carbon and high modulus para-aramids • Poor UV resistance FIBER-LINE® PROCESS FOR TECHNORA® • Coating • Twisting • Polymer Jacket Extrusion • Stranding • Overbraiding • Precision Winding FIBER-LINE® TECHNORA® PRODUCTS • Ripcords • Strength Members • Industrial Fabric Yarn • Wire Harness Yarn • Drive Belt & Hose Reinforcement • Synthetic Wire Rope WHY TECHNORA®?

WHY FIBER-LINE® RIPCORDS?

WHY FIBER-LINE® INDUSTRIAL FABRIC YARN?